Jiang L Chang

age ~61

from Philadelphia, PA

Get Report

Also known as:

Li Jiang Chang
Li Chang Jiang
Chang L Jiang
Jiang Lichang
Jiang Chung
Chang L Tiang
Jian Gli

Connected to:

Jiang Chang Phones & Addresses

Philadelphia, PA
Lamesa, TX
4210 Colden St #223, Flushing, NY 11355 • (718)3597150
Houston, TX
New York, NY
Syracuse, NY
Bayonne, NJ

Work

Company:

Broadcom corporation
Jul 2012
Position:

Scientist, staff ii firmware

Education

School / High School:

New York University, Polytechnic School of Engineering- Brooklyn, NY
2007
Specialities:

PhD in Electrical Engineering, Minor in Mathematics

Skills

Wireless communications • Signal processing • LTE/LTE-Advanced • MIMO-OFDM • Modem Firmware

Us Patents

Cyclic Guanidines, Compositions Containing Such Compounds And Methods Of Use
view source
US Patent:

7301036, Nov 27, 2007
Filed:

Dec 15, 2004
Appl. No.:

10/580183
Inventors:

Emma R. Parmee - Scotch Plains NJ, US
Ronald M. Kim - Summit NJ, US
Elizabeth A. Rouse - Edison NJ, US
Darby R. Schmidt - Clark NJ, US
Christopher Joseph Sinz - Cranford NJ, US
Jiang Chang - Westfield NJ, US
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

C07D 235/30
US Classification:

5483074
Abstract:

The present invention relates to cyclic guanidines, compositions containing such compounds and methods of treatment. The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.

Benzamidazoles, Compositions Containing Such Compounds And Methods Of Use
view source
US Patent:

7563815, Jul 21, 2009
Filed:

May 5, 2004
Appl. No.:

10/556230
Inventors:

Emma R. Parmee - Scotch Plains NJ, US
Ronald M. Kim - Summit NJ, US
Rui Liang - East Brunswick NJ, US
Jiang Chang - Westfield NJ, US
Elizabeth Ashley Rouse - Edison NJ, US
Kevin T. Chapman - Scotch Plains NJ, US
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 31/4184
C07D 235/28
US Classification:

514394, 5483054, 5483071
Abstract:

The present invention relates to substituted benzimidazoles, compositions containing such compounds and methods of treatment The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.

Cleaved Serum Response Factor In Cardiac Diagnosis And Therapy
view source
US Patent:

7582478, Sep 1, 2009
Filed:

Jan 22, 2004
Appl. No.:

10/763037
Inventors:

Robert J. Schwartz - Houston TX, US
Lei Wei - Pearland TX, US
Jiang Chang - Houston TX, US
Mark Entman - Houston TX, US
Assignee:

Baylor College of Medicine - Houston TX
International Classification:

C12N 5/00
C12N 5/02
A61K 48/00
A61K 38/30
US Classification:

435325, 514 12, 424 932, 424 936
Abstract:

The present invention is directed to the cleavage of serum response factor as it relates to cardiac disease. In specific embodiments, failing cardiac tissue is diagnosed in tissues comprising elevated cleavage of serum response factor. In further specific embodiments, heart failure is associated with cardiac myocyte apoptosis as a result of an increase in cleaved serum response factor, particularly by caspases.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
view source
US Patent:

7687534, Mar 30, 2010
Filed:

Oct 2, 2007
Appl. No.:

11/906374
Inventors:

John E. Stelmach - Westfield NJ, US
Emma R. Parmee - Scotch Plains NJ, US
James R. Tata - Westfield NJ, US
Keith G. Rosauer - Laurence Harbor NJ, US
Ronald M. Kim - Summit NJ, US
Amy R. Bittner - Scotch Plains NJ, US
Jiang Chang - Westfield NJ, US
Christopher Joseph Sinz - Cranford NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/404
C07D 209/14
US Classification:

514415, 548511
Abstract:

Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
view source
US Patent:

7968589, Jun 28, 2011
Filed:

Feb 9, 2010
Appl. No.:

12/702358
Inventors:

John E. Stelmach - Westfield NJ, US
Emma R. Parmee - Scotch Plains NJ, US
James R. Tata - Westfield NJ, US
Keith G. Rosauer - Laurence Harbor NJ, US
Ronald M. Kim - Summit NJ, US
Amy R. Bittner - Scotch Plains NJ, US
Jiang Chang - Westfield NJ, US
Christopher Joseph Sinz - Cranford NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/404
C07D 209/10
US Classification:

514415, 548511
Abstract:

Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
view source
US Patent:

7989472, Aug 2, 2011
Filed:

Mar 19, 2007
Appl. No.:

12/225056
Inventors:

Ronald M. Kim - Summit NJ, US
Emma R. Parmee - Scotch Plains NJ, US
Qiang Tan - Westfield NJ, US
Ashley Rouse Lins - Edison NJ, US
Jiang Chang - Westfield NJ, US
Cangming Yang - Highland Park NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/47
A61K 31/4184
C07D 215/00
C07D 235/04
US Classification:

514311, 546112, 546152, 546174, 546175, 5483027, 5483097, 548469, 548510, 548217, 514299, 514385, 514394
Abstract:

Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Modulators Of Ccr5 Chemokine Receptor Activity
view source
US Patent:

20020193407, Dec 19, 2002
Filed:

Oct 10, 2001
Appl. No.:

09/973920
Inventors:

Ronald Kim - Hoboken NJ, US
Jiang Chang - Westfield NJ, US
Kevin Chapman - Scotch Plains NJ, US
Sander Mills - Scotch Plains NJ, US
International Classification:

A61K031/445
A61K031/403
C07D211/26
C07D209/52
US Classification:

514/331000, 514/412000, 546/246000, 548/452000
Abstract:

Compounds of Formula I: (wherein R, R, R, R, Q, and X are defined herein) are described. The compounds are modulators of CCR5 chemokine receptor activity. The compounds are useful, for example, in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

Selective Inhibition Of Rock1 In Cardiac Therapy
view source
US Patent:

20060142193, Jun 29, 2006
Filed:

Nov 9, 2005
Appl. No.:

11/270653
Inventors:

Lei Wei - Fishers IN, US
Robert Schwartz - Houston TX, US
Jiang Chang - Houston TX, US
Mark Entman - Houston TX, US
Assignee:

BAYLOR COLLEGE OF MEDICINE - Houston TX
International Classification:

A61K 38/17
A61K 48/00
US Classification:

514012000, 514044000
Abstract:

The present invention is directed to the treatment and/or prevention of disease as it relates to Rho kinase. In specific embodiments, disease is treated and/or prevented through the administration of an agent that selectively inhibits ROCK1. In specific embodiments, it inhibits ROCK1 and not ROCK2. In other specific embodiments, the disease is cardiac disease.

Wikipedia

Yangtze River

view source

The Yangtze River, or Chang Jiang is the longest river in Asia, and the third-longest in the world. It flows for 6,300 kilometres (3,915 mi) from the glaciers on the Tibetan ...

Changjiang

view source

Changjiang Scholars Program, higher education development program in China; Changjiang Securities, a securities company in Wuhan, China; Chang Jiang (motorcycle), brand name of ...

Name / Title

Company / Classification

Phones & Addresses

Jiang Chang
Director

JKC INTERNATIONAL, INC

4117 Barnes St, Houston, TX 77007
10042 Briar Frst Dr, Houston, TX 77042

Jiang Yuen Chang
Chairman of the Board

MEN CHEN CORP
Ret Men's/Boy's Clothing

103 Lafayette St, New York, NY 10013

Resumes

Professor

view source

Location:

College Station, TX

Industry:

Higher Education

Work:

Texas A&M Health Science Center
Assistant Professor

Education:

Texas A&M University 1993 - 1999
Doctorates, Doctor of Philosophy, Physiology Wuhan University School of Medicine 1988 - 1991
Masters, Medicine Wuhan University School of Medicine 1981 - 1986
Bachelors, Bachelor of Medicine, Medicine

Skills:

Broadcom Corporation

Jul 2012 to 2000
Scientist, Staff II Firmware InterDigital Communications, LLC

Sep 2011 to 2000
Intern, Wireless System Evolution Polytechnic Institute of New York University

Sep 2007 to 2000
Research Assistant Hisilicon Technologies, Beijing, P.R.China (former ASIC Design Center of Huawei Technologies, P.R.China)

Feb 2006 to Jul 2007
Wireless Algorithm Engineer NEC Labs China

Aug 2003 to Feb 2006
Associate Researcher Communication Research Center, Harbin Institute of Technology, Harbin, P.R.China
Harbin, China
Sep 1999 to Jul 2003
Research Assistant

Education:

New York University, Polytechnic School of Engineering
Brooklyn, NY
2007 to 2011
PhD in Electrical Engineering, Minor in Mathematics Harbin Institute of Technology
Harbin, China
1997 to 1999
M.S. in Electrical and Mechanical Engineering Harbin Institute of Technology
Harbin, China
Jan 1993 to Jan 1997
B.S. in Industrial Automation Instrument

Skills:

Wireless communications, Signal processing, LTE/LTE-Advanced, MIMO-OFDM, Modem Firmware